Israeli (TA) Pharma Industry Analysis

UpdatedApr 03, 2026

DataAggregated Company Financials

Companies6

7D-1.5%
3M-10.6%
1Y-34.1%
YTDn/a

Over the last 7 days, the Pharma industry has dropped 1.5%, driven by Seach Medical Group declining 7.0%. The industry has fallen 34% in the last year.

Industry Valuation and Performance

Has the Israeli Pharma Industry valuation changed over the past few years?

Date	Market Cap	Revenue	Earnings	PE	Absolute PE	PS
Fri, 03 Apr 2026	₪411.1m	₪700.5m	-₪174,549,446.80	57.8x	-2.4x	0.6x
Sun, 01 Mar 2026	₪456.5m	₪706.6m	-₪88,191,308.90	6.8x	-5.2x	0.6x
Tue, 27 Jan 2026	₪482.6m	₪706.6m	-₪88,136,367.00	6.8x	-5.5x	0.7x
Thu, 25 Dec 2025	₪491.8m	₪706.6m	-₪93,241,307.50	6.1x	-5.3x	0.7x
Sat, 22 Nov 2025	₪557.0m	₪720.3m	-₪94,751,296.70	6.4x	-5.9x	0.8x
Mon, 20 Oct 2025	₪598.6m	₪720.3m	-₪92,746,182.70	6.8x	-6.5x	0.8x
Wed, 17 Sep 2025	₪577.0m	₪716.6m	-₪84,376,791.70	7x	-6.8x	0.8x
Fri, 15 Aug 2025	₪577.8m	₪716.7m	-₪67,218,973.90	29.5x	-8.6x	0.8x
Sun, 13 Jul 2025	₪573.1m	₪716.7m	-₪71,474,767.90	30x	-8x	0.8x
Tue, 10 Jun 2025	₪571.5m	₪716.7m	-₪72,076,997.10	30.8x	-7.9x	0.8x
Thu, 08 May 2025	₪589.3m	₪732.8m	-₪82,104,508.00	14.5x	-7.2x	0.8x
Sat, 05 Apr 2025	₪544.5m	₪766.6m	-₪81,109,008.00	14.1x	-6.7x	0.7x
Mon, 03 Mar 2025	₪674.3m	₪828.6m	-₪180,581,929.40	21.8x	-3.7x	0.8x
Wed, 29 Jan 2025	₪677.0m	₪828.6m	-₪180,770,789.00	20.7x	-3.7x	0.8x
Fri, 27 Dec 2024	₪680.6m	₪828.6m	-₪181,183,482.20	19.9x	-3.8x	0.8x
Sun, 24 Nov 2024	₪595.2m	₪816.0m	-₪184,026,045.40	23.8x	-3.2x	0.7x
Tue, 22 Oct 2024	₪644.8m	₪808.7m	-₪205,869,823.50	22.6x	-3.1x	0.8x
Thu, 19 Sep 2024	₪673.4m	₪810.4m	-₪244,968,731.90	22.1x	-2.7x	0.8x
Sat, 17 Aug 2024	₪620.1m	₪901.7m	-₪261,738,599.20	n/a	-2.4x	0.7x
Mon, 15 Jul 2024	₪731.4m	₪901.7m	-₪260,368,827.20	n/a	-2.8x	0.8x
Wed, 12 Jun 2024	₪710.3m	₪891.0m	-₪258,325,708.80	n/a	-2.7x	0.8x
Fri, 10 May 2024	₪853.4m	₪886.2m	-₪261,041,096.00	n/a	-3.3x	1x
Sun, 07 Apr 2024	₪770.4m	₪950.0m	-₪182,314,128.00	21.2x	-4.2x	0.8x
Tue, 05 Mar 2024	₪673.1m	₪972.3m	-₪210,870,713.20	15.4x	-3.2x	0.7x
Thu, 01 Feb 2024	₪545.2m	₪972.3m	-₪212,385,143.00	10.1x	-2.6x	0.6x
Sat, 30 Dec 2023	₪563.8m	₪972.3m	-₪211,671,107.00	10x	-2.7x	0.6x
Mon, 27 Nov 2023	₪578.9m	₪958.8m	-₪209,122,533.00	9.6x	-2.8x	0.6x
Wed, 25 Oct 2023	₪654.8m	₪958.8m	-₪215,032,868.00	9.9x	-3x	0.7x
Fri, 22 Sep 2023	₪681.9m	₪958.8m	-₪209,803,438.00	13.3x	-3.3x	0.7x
Sun, 20 Aug 2023	₪646.1m	₪918.8m	-₪128,402,228.00	8.3x	-5x	0.7x
Tue, 18 Jul 2023	₪664.6m	₪918.8m	-₪125,060,601.00	8.5x	-5.3x	0.7x
Thu, 15 Jun 2023	₪768.9m	₪918.8m	-₪124,102,001.00	11.1x	-6.2x	0.8x
Sat, 13 May 2023	₪850.1m	₪887.2m	-₪122,361,736.00	9x	-6.9x	1x
Mon, 10 Apr 2023	₪850.0m	₪855.1m	-₪86,552,318.00	10.2x	-9.8x	1x

Price to Earnings Ratio

-9.8x

Mon, 10 Apr 2023

Current Industry PE

Investors are pessimistic on the Israeli Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.

The industry is trading close to its 3-year average PS ratio of 0.76x.

Past Earnings Growth

The earnings for companies in the Pharmaceuticals industry have deteriorated over the last three years.
Revenues have also declined 6.4% per year.
This means overall sales from these companies are declining and losses are subsequently expanding as well.